Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.53 |
| ▸ | MVD | P53602 | 4/20 | 0.46 |
| ▸ | FNTA | P49354 | 4/20 | 0.38 |
| ▸ | FNTB | P49356 | 3/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.37 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL155704 | 1.00 | BTN3A1 (0.53) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL1173655 | 0.87 | ALDH1A1 (0.41) | BTN3A1 | |
| SCHEMBL3775300 | 0.86 | BTN3A1 (0.52) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL22319797 | 0.86 | BTN3A1 (0.45) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL22319792 | 0.86 | BTN3A1 (0.45) | BTN3A1MVDFNTAFNTBGGPS1 | |
| Dimethylallyl Diphosphate SCHEMBL31695014 | 0.85 | BTN3A1 (0.73) | BTN3A1FNTAFNTBGGPS1PGGT1B | |
| SCHEMBL4971483 | 0.85 | BTN3A1 (0.47) | BTN3A1MVDGGPS1 | |
| SCHEMBL10796477 | 0.85 | BTN3A1 (0.47) | BTN3A1MVDGGPS1 | |
| SCHEMBL4967747 | 0.85 | BTN3A1 (0.47) | BTN3A1MVDGGPS1 | |
| SCHEMBL11677875 | 0.85 | ALDH1A1 (0.39) | BTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 702 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230145729-A1 | INDOLE DITERPENE BIOSYNTHESIS | GRASSLANZ TECHNOLOGY LIMITED (NZ) | 2023-05-11 | — | — | US | claimed |
| EP-4125340-A1 | INDOLE DITERPENE BIOSYNTHESIS | Grasslanz Technology Limited (NZ) | 2023-02-08 | — | — | EP | claimed |
| WO-2022221338-A2 | SYSTEMS, MICROORGANISMS, OR METHODS FOR WASTE PET VALORIZATION | WASHINGTON UNIVERSITY (US) | 2022-10-20 | — | — | WO | claimed |
| CN-114934040-A | Method for synthesizing isoprene by catalyzing mevalonic acid in vitro with immobilized enzyme | 青岛科技大学 | 2022-08-23 | — | — | CN | claimed |
| US-20210324425-A1 | CELL-FREE METABOLIC PATHWAY OPTIMIZATION THROUGH REMOVAL OF SELECT PROTEINS | UT-BATTELLE, LLC | 2021-10-21 | — | — | US | claimed |
| WO-2021201700-A1 | INDOLE DITERPENE BIOSYNTHESIS | GRASSLANZ TECHNOLOGY LIMITED (NZ) | 2021-10-07 | — | — | WO | claimed |
| US-10633675-B2 | Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-04-28 | — | — | US | claimed |
| US-20200080115-A1 | Cannabinoid Production by Synthetic In Vivo Means | Biotic Sciences LLC | 2020-03-12 | — | — | US | claimed |
| US-20190225945-A1 | PRODUCTION OF CITRONELLAL AND CITRONELLOL IN RECOMBINANT HOSTS | EVOLVA SA (SE) | 2019-07-25 | — | — | US | claimed |
| US-20190017077-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-01-17 | — | — | US | claimed |
| US-20020147371-A1 | Fermentative carotenoid production | DSM NUTRITIONAL PRODUCTS, INC. | 2002-10-10 | — | — | US | claimed |
| EP-0471056-B1 | BIOSYNTHESIS OF CAROTENOIDS IN GENETICALLY ENGINEERED HOSTS | BP CORP NORTH AMERICA INC (US) | 2001-10-17 | — | — | EP | claimed |
| US-6291204-B1 | CULTURING GENETICALLY ENGINEERED CELL CONTAINING FARNESYL PYROPHOSPHATE AND ISOPENTYL PYROPHOSPHATE TO EXPRESS ZEAXANTHIN; DNA SEQUENCES ENCODE GERANYLGERANYL PYROPHOSPHATE SYNTHASE AND OTHER ENZYMES FROM FLAVOBACTERIUM | ROCHE VITAMINS INC. | 2001-09-18 | — | — | US | claimed |
| US-6284506-B1 | MOLECULAR HYBRIDIZATION; CAROTENOID AND ASTAXANTHIN PRODUCTION; GENE EXPRESSION OF MELAVONATE OR ISOPENTENYL TO FARNESYL PYROPHOSPHATE BIOSYNTHETIC ENZYMES | ROCHE VITAMINS INC. | 2001-09-04 | — | — | US | claimed |
| US-6207409-B1 | CULTURING A RECOMBINANT CELL THAT HAS BEEN TRANSFORMED WITH AN EXPRESSION VECTOR HAVING A REGULATORY SEQUENCE AND A POLYNUCLEOTIDE COMPRISING A DNA SEQUENCE WHICH ENDCODES GERANYL/GERANYLPYROPHOSPHATE OF FLAVOBACTERIUM SPECIES | ROCHE VITAMINS INC. | 2001-03-27 | — | — | US | claimed |
| US-6124113-A | CULTURING IN SUITABLE MEDIUM CONTAINING FARNESYL PYROPHOSPHATE AND ISOPENTYL PYROPHOSPHATE UNDER CONDITIONS SUFFICIENT FOR EXPRESSION OF ENZYMES WHICH CATALYZE CONVERSION OF THE FARNESYL AND ISOPENTYL PYROPHOSPHATES TO ZEAXANTHIN | ROCHE VITAMINS INC. (US) | 2000-09-26 | — | — | US | claimed |
| EP-0889952-A1 | GENES OF CAROTENOID BIOSYNTHESIS AND METABOLISM AND A SYSTEM FOR SCREENING FOR SUCH GENES | UNIVERSITY OF MARYLAND COLLEGE PARK (US) | 1999-01-13 | — | — | EP | claimed |
| US-5684238-A | Biosynthesis of zeaxanthin and glycosylated zeaxanthin in genetically engineered hosts | AMOCO CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| WO-1997036998-A1 | GENES OF CAROTENOID BIOSYNTHESIS AND METABOLISM AND A SYSTEM FOR SCREENING FOR SUCH GENES | UNIVERSITY OF MARYLAND COLLEGE PARK (US) | 1997-10-09 | — | — | WO | claimed |
| US-5545816-A | DNA SEGMENTS ENCODING THE ERWINIA HERBICOLA ENZYMES GERANYLGERANYL PYROPHOSPHATE SYNTHASE AND PHYTOENE SYNTHASE | AMOCO CORPORATION (US) | 1996-08-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230145729-A1 | INDOLE DITERPENE BIOSYNTHESIS | INMT, PNMT, COASY | BTN3A1 3070/4885MVD 125/4885FNTA 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.